FDA Investigator M Edith Snyder
M Edith Snyder has conducted inspections on 8 sites in 3 countries as of 26 Jul 2004. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
8
Last Inspection Date:
26 Jul 2004
Investigator Role:
FDA Investigation Participant
Redica ID:
Countries of Inspections:
United States of America,
Canada,
Australia
FDA Investigators that have inspected at least one site in common with M Edith Snyder:
Anthony J Ladner,
Anthony L Nicoli,
April L Young,
Charles R Cote, RIC,
Courtney R Ingalsbe,
Courtney R Tiegs,
Ct Viswanathan, PhD,
Darlene L Krieger,
Darren D Holaday,
David B Wieneke,
David J Hafner,
Don H Bark, PhD,
Edward D Mcdonald,
Fannie M Harrell,
Grant M Ruis,
Gregory W Smith,
Ivan E Reyes,
Jessica L Pressley,
Jonell R O'neil,
Kristy E Zuroski,
Kyle J Mccracken,
Margaret M Lubbers Solberg,
Marie A Fadden,
Melissa I Michurski,
Meyer J Slobotsky,
Nebil A Oumer,
Nicole C Victoria, PhD,
Regina T Brown,
Ronald R Ruff,
Ross J Grigsby,
Sandra Sejdinovic,
Scott A Golladay,
Scott B Laufenberg,
Sharon L Matson,
Tara C Singh
M Edith Snyder's Documents
Publish Date | Document Type | Title |
---|---|---|
January, 2004 | EIR | Covance Clinical Research Unit Irb - EIR, 2004-01-16 |
June, 2000 | FDA 483 | Hawkins, Inc. - Form 483, 2000-06-28 |
March, 2001 | EIR | Piramal Healthcare (Canada) Limited - EIR, 2001-06-04 |
March, 2001 | FDA 483 | Piramal Healthcare (Canada) Limited - Form 483, 2001-03-15 |
June, 2001 | EIR | Upsher-Smith Laboratories, LLC - EIR, 2001-06-28 |
January, 2004 | FDA 483 | Tetrionics Inc - Form 483, 2004-01-15 |
February, 2000 | EIR | CMAX Pty., Ltd., S.A. - EIR, 2007-02-08 |
June, 2000 | EIR | Hawkins, Inc. - EIR, 2000-06-29 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more